Product
Regular Insulin + Pramlintide
1 clinical trial
3 indications
Indication
Diabetes MellitusIndication
Type 1Indication
Diabetes Mellitus, Type 1Clinical trial
A Phase 2, Single-Dose, Randomized, Open-Label, Active-Controlled, Crossover, Pharmacodynamic, and Pharmacokinetic Comparative Study of a Novel Pramlintide-Insulin Co-Formulation in Adults With Type 1 Diabetes MellitusStatus: Completed, Estimated PCD: 2020-04-02